Journal of Urologic Oncology

Renal Cell Carcinoma

Comparison of Outcomes Between Radical Nephrectomy and Partial Nephrectomy in Clinical T2 Renal Cell Carcinoma: A Retrospective Korean Renal Cell Carcinoma Cohort Study: Younsoo Chung, Seok-Soo Byun, Sung Kyu Hong, Sangchul Lee, Chang Wook Jeong, Seok Ho Kang, Sung-Hoo Hong, Ji Youl Lee, Yong-June Kim, Jinsoo Chung, Eu Chang Hwang, Tae Gyun Kwon, Jung Kwon Kim; Journal of Urologic Oncology. 2024;22(2):136-143. Published online July 31, 2024; DOI: https://doi.org/10.22465/juo.244800360018
Cited By 1; Full text PubReader ePub PDF Supplementary Material

Kidney Cancer

Targeted Therapy Following Metastasectomy for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysis: Hui Mo Gu, Seung Il Jung, Dongdeuk Kwon, Myung Ha Kim, Jae Hung Jung, Mi Ah Han, Seung Hwan Lee, In Gab Jeong, Sun Il Kim, Eu Chang Hwang; Journal of Urologic Oncology. 2024;22(1):34-41. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600140007
Cited By 1; Full text PubReader ePub PDF Supplementary Material

Clinical Significance of Rab27a as a Urinary Biomarker in Patients With Bladder Cancer: Ja Yoon Ku, Md Nazmul Huda, Eu Chang Hwang, Chan Ho Lee, Kyung Hwan Kim, Dong Deuk Kwon, Hong Koo Ha; Journal of Urologic Oncology. 2023;21(3):277-277. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.err.kjuo.2022.20.1.52
Corrects: J Urol Oncol 2022;20(1):52; Full text PubReader ePub PDF

Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma

Korean Urologic Oncology Society Guidelines: Does Angioembolization Improve the Quality of Life for Renal Cell Carcinoma Patients With Intractable Symptoms Who Are Unfit for Surgery?: Ja Yoon Ku, Hui Mo Gu, Seong Hyeon Yu, Eu Chang Hwang, Mi Ah Han, Jae Hung Jung, Hunju Lee, Myung Ha Kim, Cheol Kwak, Sun Il Kim, for the Korean Urologic Oncology Society Guideline Development Committee, Korean Renal Cancer Study Group; Journal of Urologic Oncology. 2023;21(2):140-147. Published online July 31, 2023; DOI: https://doi.org/10.22465/juo.234600180009
Cited By 1; Full text PubReader ePub PDF Supplementary Material

Contemporary Management of Small Renal Masses by Urologic Oncologists: A 2022 Korean Renal Cancer Study Group Practice Pattern Survey: Joongwon Choi, Cheryn Song, Jungyo Suh, Minyong Kang, Chang Il Choi, Hyeong Dong Yuk, Chan Ho Lee, Jung Kwon Kim, Jung Ki Jo, Won Sik Ham, Eu Chang Hwang, Chang Wook Jeong, Young Hwii Ko, Jae Young Park, Seong Il Seo, Byung Kwan Park, Jinsoo Chung, Cheol Kwak, Sung-Hoo Hong; Journal of Urologic Oncology. 2023;21(1):59-69. Published online March 31, 2023; DOI: https://doi.org/10.22465/juo.234600120006
Cited By 1; Full text PubReader ePub PDF

2021 Consensus Statements on the Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma From the Korean Renal Cancer Study Group (KRoCS): Chan Ho Lee, Minyong Kang, Cheol Kwak, Sung Han Kim, Jung Kwon Kim, Jae Young Park, Seong Il Seo, Ill Young Seo, Jungyo Suh, Wan Song, Cheryn Song, Hyeong Dong Yuk, Sangchul Lee, Hyung Ho Lee, Jinsoo Chung, Chang Wook Jeong, Jung Ki Jo, Chang Il Choi, Seol Ho Choo, Jun Hyun Han, Eu Chang Hwang, Miso Kim, Chan Kim, Seock Hwan Choi, Sung-Hoo Hong; Korean J Urol Oncol. 2022;20(3):151-162. Published online August 25, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.3.151
Cited By 1; Full text PubReader ePub PDF

Clinical Significance of Rab27a as a Urinary Biomarker in Patients With Bladder Cancer: Ja Yoon Ku, Eu Chang Hwang, Chan Ho Lee, Kyung Hwan Kim, Dong Deuk Kwon, Hong Koo Ha; Korean J Urol Oncol. 2022;20(1):52-58. Published online February 24, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.1.52
Correction in: J Urol Oncol 2023;21(3):277; Full text PubReader ePub PDF

Comparison of Synchronous and Metachronous Primary Carcinomas of the Bladder and Prostate: Ho Seok Chung, Young Ho Seo, Seung Il Jung, Eu Chang Hwang, Taek Won Kang, Dong Deuk Kwon; Korean J Urol Oncol. 2017;15(1):44-50. Published online April 26, 2017; DOI: https://doi.org/10.22465/kjuo.2017.15.1.44; Full text PubReader ePub PDF

Risk Determination for Localised Renal Cell Carcinomas under 4 cm or Less: A Multi-institutional Analysis: Kwangmo Kim, Sangchul Lee, Sung Kyu Hong, Cheol Kwak, Yong-June Kim, Jinsoo Chung, Seok Ho Kang, Eu Chang Hwang, Sung Hoo Hong, Seok-Soo Byun; Korean J Urol Oncol. 2016;14(3):138-143. Published online December 31, 2016; DOI: https://doi.org/10.22465/kjuo.2016.14.3.138; Full text PubReader ePub PDF

5,578	New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
5,029	The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer
4,372	The Present and Future of Intravesical Therapy in Bladder Cancer
4,321	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
4,296	Complex Epidemiology of Prostate Cancer in Asian Countries

Cited By 7	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 4	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
Cited By 4	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 3	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By 2	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use

Search